SCHEMBL29802995

SCHEMBL29802995

COc1cc(N2CCC3(CC2)CCN(C2CNC2)CC3)c(C)cc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
LMNA P02545 3/20 0.40
SIRT6 Q8N6T7 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 1/20 0.37
DRD2 P14416 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 4/20 0.36
KMT2A Q03164 2/20 0.36
FFAR4 Q5NUL3 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28795481 0.96 ALDH1A1 (0.37) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL28795244 0.93 ALDH1A1 (0.41) ALDH1A1LMNASIRT6SMN1; SMN2HTT
Trifluoroacetic Acid SCHEMBL28795110 0.93 FFAR4 (0.38) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL29802998 0.90 DRD2 (0.41) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL28795201 0.87 ALDH1A1 (0.41) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL28795309 0.86 ALDH1A1 (0.41) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL29803107 0.86 DRD2 (0.52) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL28795345 0.86 DRD2 (0.52) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL22182766 0.85 ALDH1A1 (0.44) ALDH1A1LMNASIRT6SMN1; SMN2HTT
SCHEMBL29803025 0.85 ALDH1A1 (0.44) ALDH1A1LMNASIRT6SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805303-A Molecule with double functions of degrading EGFR (epidermal growth factor receptor), composition and pharmaceutical application thereof 海思科医药集团股份有限公司 2022-07-29 CN disclosed